Left ventricular strain and myocardial work in short-term peritoneal dialysis patients

Ren Fail. 2023;45(2):2284838. doi: 10.1080/0886022X.2023.2284838. Epub 2023 Nov 28.

Abstract

Background: Initiation of dialysis encompasses new cardiovascular challenges on patients with end-stage renal disease (ESRD). This study used two-dimensional speckle-tracking echocardiography (2D-STE) to investigate the change of left ventricular (LV) myocardial function undergoing peritoneal dialysis (PD) within 1-3 months.

Methods: A total of 56 patients with ESRD and 27 healthy controls were enrolled in this prospective study. Mean duration of PD was 44.41 ± 16.44 days. We evaluated LV myocardial function of patients with ESRD in baseline and within 1-3 months after PD by 2D-STE with global longitudinal strains (GLS) and myocardial work (MW). Based on the level of serum phosphate before PD, patients were divided into two groups: the group with normal serum phosphate or hyperphosphatemia.

Results: Compared with healthy controls, patients with ESRD had impaired GLS (p < .001) and increased global work index (GWI) (p = .034), global constructive work (GCW) (p < .001), global wasted work (GWW) (p < .001), and lower global work efficiency (GWE) (p = .002). After PD therapy, GWI (p = .001), GCW (p < .001), and GWW (p = .023) decreased and closed to healthy subjects (p > .05) and no significant improvement was observed in GLS (p = .387). GLS of basal segments worsened in the hyperphosphatemia group (p = .005) and GWW reduced remarkably in the group with normal serum phosphate after PD treatment (p = .008). The change of left ventricular internal diameter in diastole (LVIDd) was the only parameter influenced GWI in post-dialysis patients (β = 0.324, p = .013).

Conclusions: Short-term PD treatment improved LV MW in ESRD patients. They benefited more when receiving treatment before the increase of serum phosphorus.

Keywords: End-stage renal disease; myocardial work; peritoneal dialysis; strain; two-dimensional speckle-tracking echocardiography.

MeSH terms

  • Humans
  • Hyperphosphatemia*
  • Kidney Failure, Chronic* / complications
  • Kidney Failure, Chronic* / therapy
  • Peritoneal Dialysis* / adverse effects
  • Phosphates
  • Prospective Studies
  • Stroke Volume
  • Ventricular Function, Left

Substances

  • Phosphates

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.